Linden Capital Partners, a private equity firm agreed to acquire Collagen Matrix, a developer and manufacturer of collagen-based medical products used for tissue and bone repair and regeneration across orthopedic, sports medicine, dental, and neurosurgery end markets. Financial terms were not disclosed. “The CMI team’s unique understanding of collagen-based technologies along with their commitment to innovation and quality manufacturing make CMI stand out as a leading biomaterials developer and manufacturer,” Gerard Moufflet, Linden Operating Partner.